May 3, 2022

Holland & Knight Health Dose: May 3, 2022

Miranda A. Franco
Holland & Knight Health Dose

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • COVID-19 Relief Funding
  • User Fee Agreements & Other Health Priorities in the House
  • Healthy Future Task Force Releases Set of Treatment Recommendations
  • CMS Releases Final 2023 Medicate Advantage (MA)/Part D Rule
  • CMS Finalizes 2023 Benefit and Payment Parameters for Marketplace Plans
  • FDA Sets June Dates to Review COVID-19 Vaccines
  • FDA Revamps Office of Product Evaluation and Quality as Path Forward for Reimbursing FDA-Approved Breakthrough Devices Remains Unclear
  • MIPS 2022 Extreme and Uncontrollable Circumstances Portal Now Open

Read the full Health Dose »

Related Insights